UR9 Relative Valuation - Clinuvel Pharmaceuticals Ltd - Alpha Spread

Dashboard Market News Pricing Contact Us

Watchlist Manager

Watchlist

Price: 4.9 EUR Market Closed

Market Cap: €242.1m

Multiples-Based Value

UR9 price has not been updated for more than 2 years. This may indicate that the stock has been delisted.

The Multiples-Based Value for Clinuvel Pharmaceuticals Ltd (UR9) under the Base Case is 5.5 EUR. Compared with the current market price of 4.9 EUR, the stock appears Undervalued by 11% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

UR9 Multiples-Based Value

Undervaluation 11%

Multiples-Based Value

Price €4.9

Valuation Multiples

Multiples Across Competitors

Continue UR9 Research

Relative Valuation

Wall St Estimates

Back to Top

Join 359,000+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.